Stroke and other forms of cerebral ischemia occur when blood flow to the brain is temporarily reduced, depriving neurons of oxygen and nutrients and often leading to memory loss, inflammation, and long-term brain damage. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in hemp—could help protect the brain following transient global cerebral […]
Category: Brain
Clinical Study Shows CBD May Support Anxiety Reduction and Cognitive Function (pub. Aug 2025)
Anxiety disorders can affect mood, sleep, and overall quality of life, leading researchers to explore new supportive approaches. This open-label pilot study evaluated a hemp-derived, full-spectrum cannabidiol (CBD) product in adults experiencing moderate to severe anxiety. Over a six-week period, participants took a daily CBD dose designed to resemble products commonly available in the marketplace. […]
Cannabichromene (CBC), Cannabigerol (CBG), and Related Compounds Show Early Antitumor Activity Against Glioma (pub. June 2025)
Gliomas are aggressive brain tumors with poor prognosis, and new therapeutic strategies are urgently needed. This study used a combined in silico (computer modeling) and in vitro (laboratory cell) approach to evaluate whether compounds from Cannabis sativa—including cannabichromene (CBC) and cannabigerol (CBG)—as well as related natural molecules, may inhibit the growth of malignant glioma cells. […]